InMed Pharmaceuticals Statistics

Total Valuation

INM has a market cap or net worth of $1.76 million. The enterprise value is -$7.46 million.

Market Cap	1.76M
Enterprise Value	-7.46M

Important Dates

The next estimated earnings date is Monday, May 13, 2024.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

INM has 6.06 million shares outstanding. The number of shares has increased by 246.59% in one year.

Shares Outstanding	6.06M
Shares Change (YoY)	+246.59%
Shares Change (QoQ)	+139.57%
Owned by Insiders (%)	1.36%
Owned by Institutions (%)	13.29%
Float	4.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.32
Forward PS	n/a
PB Ratio	0.14
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.03, with a Debt / Equity ratio of 0.03.

Current Ratio	7.03
Quick Ratio	5.92
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -54.30% and return on invested capital (ROIC) is -53.25%.

Return on Equity (ROE)	-54.30%
Return on Assets (ROA)	-46.20%
Return on Capital (ROIC)	-53.25%
Revenue Per Employee	$422,081
Profits Per Employee	-$488,565
Employee Count	13
Asset Turnover	0.40
Inventory Turnover	2.87

Taxes

In the past 12 months, INM has paid $3,300 in taxes.

Income Tax	3,300
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.70% in the last 52 weeks. The beta is 0.48, so INM's price volatility has been lower than the market average.

Beta (1Y)	0.48
52-Week Price Change	-77.70%
50-Day Moving Average	0.36
200-Day Moving Average	0.57
Relative Strength Index (RSI)	34.40
Average Volume (30 Days)	308,296

Short Selling Information

The latest short interest is 10,336, so 0.17% of the outstanding shares have been sold short.

Short Interest	10,336
Short Previous Month	56,969
Short % of Shares Out	0.17%
Short % of Float	0.21%
Short Ratio (days to cover)	0.05

Income Statement

In the last 12 months, INM had revenue of $5.49 million and -$6.35 million in losses. Loss per share was -$1.27.

Revenue	5.49M
Gross Profit	2.11M
Operating Income	-6.99M
Pretax Income	-6.35M
Net Income	-6.35M
EBITDA	-5.75M
EBIT	-6.35M
Loss Per Share	-$1.27

Full Income Statement

Balance Sheet

The company has $9.58 million in cash and $364,190 in debt, giving a net cash position of $9.22 million or $1.52 per share.

Cash & Cash Equivalents	9.58M
Total Debt	364,190
Net Cash	9.22M
Net Cash Per Share	$1.52
Equity / Book Value	12.77M
Book Value Per Share	2.11
Working Capital	10.13M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.34 million and capital expenditures -$171,095, giving a free cash flow of -$6.51 million.

Operating Cash Flow	-6.34M
Capital Expenditures	-171,095
Free Cash Flow	-6.51M
FCF Per Share	-$0.82

Full Cash Flow Statement

Margins

Gross margin is 38.42%, with operating and profit margins of -127.48% and -115.75%.

Gross Margin	38.42%
Operating Margin	-127.48%
Pretax Margin	-115.69%
Profit Margin	-115.75%
EBITDA Margin	-104.72%
EBIT Margin	-115.69%
FCF Margin	-118.61%

Dividends & Yields

INM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-246.59%
Shareholder Yield	-246.59%
Earnings Yield	-361.59%
FCF Yield	-370.51%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on September 7, 2022. It was a reverse split with a ratio of 1:25.

Last Split Date	Sep 7, 2022
Split Type	Reverse
Split Ratio	1:25

Scores

INM has an Altman Z-Score of -9.47 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.47
Piotroski F-Score	4